Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Kyorin patent covers new NK1 antagonists for urinary incontinence and other uses

Sep. 8, 2003

Second approvable letter issued for duloxetine

Sep. 4, 2003

Bayer researchers describe two novel series of Rho kinase inhibitors

Sep. 3, 2003

Levitra receives FDA approval

Aug. 25, 2003

Preliminary results of North American Cystistat trial for interstitial cystitis

Aug. 22, 2003

Improved safety profile for transdermal oxybutynin vs. oral tolterodine in overactive bladder

Aug. 19, 2003

Yamanouchi and GlaxoSmithKline to copromote Vesicare in U.S.

Aug. 13, 2003

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Aug. 12, 2003

Levitra is effective in men of diverse ethnic origin

Aug. 11, 2003

Collaborative Study Group to conduct KRX-101 phase II/III program

Aug. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...